ESR1 and neoplasm: However, there are also reports demonstrating that RA can bind with other receptors, including estrogen receptor α or peroxisome proliferator‐activated receptors (PPAR) β/δ, which then activates oncogenes such as c‐MYC and cyclin D1 and thereby promotes tumor cell proliferation, drug resistance, and inhibition of apoptosis.44